|

UDCA (Ursodeoxycholic acid) Clinical Trials

3 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Xijing Hospital of Digestive Diseases1
  • Phenomen Pharma1
  • Jinling Hospital, China1

Indications

  • Liver Disease2
  • Fatty Liver, Alcoholic1
  • Nonalcoholic Fatty Liver (NAFL)1
  • Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)1
  • Nonalcoholic Fatty Liver Disease (NAFLD)1

Other3 trials

FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy
Phase 3
Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
N/A
Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.